Evidence map›Paper›PMID 26608753›Full record

ArticleEuropean journal of neurology2016

Gait as a biomarker of cognitive impairment and dementia syndromes. Quo vadis?

M Montero-Odasso

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in European journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Associations of Gait Speed, Cadence, Gait Stability Ratio, and Body Balance with Falls in Older Adults.International journal of environmental research and public health · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Consensus on Shared Measures of Mobility and Cognition: From the Canadian Consortium on Neurodegeneration in Aging (CCNA).The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Article
  18. Article
  19. Article
  20. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

M Montero-OdassoGait and Brain Laboratory, Parkwood Institute, Lawson Health Research Institute, London, ON, Canada. mmontero@uwo.ca.
Parkwood Institute · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GaitBiomarkersCognition DisordersDementiaHumansSyndromeBiomarkers

Identifiers

PMID26608753
OpenAlexW2175915319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.